B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis

Autoimmunity. 2015 Jun;48(4):201-7. doi: 10.3109/08916934.2014.992517. Epub 2014 Dec 18.

Abstract

B cells from myasthenia gravis (MG) patients with autoantibodies (Aab) against acetylcholine receptor (AChR), muscle-specific kinase (MuSK) or with no detectable Aab were investigated as cytokine producing cells in this study. B cells were evaluated for memory phenotypes and expressions of IL-10, IL-6 and IL-12A. Induced productions of IL-10, IL-6, IL-12p40, TNF-α and LT from isolated B cells in vitro were measured by immunoassays. MG patients receiving immunosuppressive treatment had higher proportions of memory B cells compared with healthy controls and untreated patients. With CD40 stimulation MG patients produced significantly lower levels of IL-10, IL-6. With CD40 and B cell receptor stimulation of B cells, TNF-α production also decreased in addition to these cytokines. The lower levels of these cytokine productions were not related to treatment. Our results confirm a disturbance of B cell subpopulations in MG subgroups on immunosuppressive treatment. B cell derived IL-10, IL-6 and TNF-α are down-regulated in MG, irrespective of different antibody productions. Ineffective cytokine production by B cells may be a susceptibility factor in dysregulation of autoimmune Aab production.

Keywords: Autoantibody; B cell; cytokine; myasthenia gravis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Autoantibodies / immunology
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism*
  • Child
  • Cytokines / biosynthesis
  • Cytokines / genetics
  • Female
  • Gene Expression
  • Humans
  • Immunophenotyping
  • Immunosuppressive Agents / therapeutic use
  • Interleukin-10 / biosynthesis*
  • Interleukin-10 / genetics
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / genetics
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Myasthenia Gravis / diagnosis
  • Myasthenia Gravis / genetics
  • Myasthenia Gravis / immunology*
  • Myasthenia Gravis / metabolism*
  • Myasthenia Gravis / therapy
  • Phenotype
  • Receptors, Cholinergic / immunology
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / genetics
  • Young Adult

Substances

  • Autoantibodies
  • Cytokines
  • Immunosuppressive Agents
  • Interleukin-6
  • Receptors, Cholinergic
  • Tumor Necrosis Factor-alpha
  • Interleukin-10